Skip to main content
. Author manuscript; available in PMC: 2022 Jul 13.
Published in final edited form as: J Am Coll Cardiol. 2021 Jul 13;78(2):126–138. doi: 10.1016/j.jacc.2021.04.092

Central Illustration: Kaplan-Meier Estimates of the Primary Composite Endpoint Among Racial and Ethnic Minorities and Non-minorities by Randomized Treatment in CABANA.

Central Illustration:

Kaplan-Meier estimates of the cumulative risk of having a primary endpoint event by intention-to-treat analysis. In the non-minority group, the outcomes do not differ significantly between treatment groups. In the racial and ethnic minority subgroup, patients randomized to ablation have a lower risk of having a primary endpoint event out to 4 years compared to drug therapy alone. CI=confidence interval.